Regression valuation
Fit an ordinary least squares regression of a valuation multiple against a fundamental driver. Each company's residual quantifies how much it trades above or below where the comp set says it should. Inspired by Meritech's growth-adjusted multiple framework.Snapshot: 2026-08-04.
All sectorsApplication SoftwareInfrastructure & Data SoftwareCybersecurityFintechInternet & Digital CommerceConsumer Internet, Media & GamingHealthcare ServicesMedical Devices & DiagnosticsSemiconductorsPharma & BiotechIndustrial, Aerospace & DefenseFinancial ServicesBusiness ServicesUtilitiesEnergyMaterialsTransportationConsumer DiscretionaryConsumer StaplesReal EstateCommunications & Telecom
Universe: Pharma & Biotech · 3 companies
Model
y = -43.93·x + 5.45
n = 3 · R² = 0.896
Most undervalued vs. model
Trading below the regression line
| Ticker | Actual | Model | Residual |
|---|---|---|---|
| BAYRYBayer AG | 1.9x | 2.7x | -31.4% |
| RHHBYRoche Holding AG | 5.9x | 5.6x | 5.0% |
| GRFSGrifols, S.A. | 1.9x | 1.3x | 44.2% |
Most overvalued vs. model
Trading above the regression line
| Ticker | Actual | Model | Residual |
|---|---|---|---|
| GRFSGrifols, S.A. | 1.9x | 1.3x | 44.2% |
| RHHBYRoche Holding AG | 5.9x | 5.6x | 5.0% |
| BAYRYBayer AG | 1.9x | 2.7x | -31.4% |